Day: September 16, 2025
PRINCETON, N.J., Sept. 16, 2025 (GLOBE NEWSWIRE) — Close-Up Intl, a global leader in AI-powered CRM market data and business intelligence solutions for the pharmaceutical industry, has announced it acquired MobileDotRep, a life sciences CRM solution provider based out of Thousand Oaks, CA. This acquisition is another milestone for Close-Up, who has been a pioneer in pharma CRM since 1994 and a 5-Star rated Pharma CRM provider on Gartner’s Peer Insights: https://www.gartner.com/reviews/market/crm-in-life-sciences
“We are pleased to further expand our Global and US pharma CRM presence, especially with the separation of Veeva and Salesforce, which presents a tremendous opportunity for Close-Up to further expand our success converting CRM clients in the United States,” commented Robert Thomas, Chief Commercial Officer of Close-Up Intl....
DAVIDsTEA Stays the Course in the Second Quarter
Written by Customer Service on . Posted in Earnings Releases And Operating Results.
Sales reached $11.1 million, up 0.5% year-over-year
Gross profit margin attained 47.2%, down marginally by 0.1%
Net loss remained stable at $1.6 million
Adjusted EBITDA was negative $0.2 million compared to negative $0.3 million in Q2 2024
New stores earmarked for South Shore of Montreal, Quebec City and MississaugaMONTREAL, Sept. 16, 2025 (GLOBE NEWSWIRE) — DAVIDsTEA Inc. (TSX-Venture: DTEA) (“DAVIDsTEA” or the “Company”), a leading North American tea merchant, announced today its financial results for the second quarter of fiscal 2025 ended August 2, 2025.
“DAVIDsTEA stayed the course with its omnichannel growth strategy in the second quarter of 2025, supported by retail store and wholesale channel sales increases of 9.1% and 2.5% year-over-year, respectively,” said Sarah Segal, Chief Executive Officer and Chief Brand Officer,...
Strive Announces Acquisition of MSTR True North Inc. Appoints Jeff Walton as Chief Risk Officer & CEO of True North
Written by Customer Service on . Posted in Mergers And Acquisitions.
Dallas, TX, Sept. 16, 2025 (GLOBE NEWSWIRE) — Strive, Inc. announces a strategic acquisition of MSTR True North Inc. (True North) in a de minimis cash transaction. True North is cash flow positive and the transaction synergies are expected to allow enhanced platform expansion without additional cost. This move cements Strive’s position at the forefront of Bitcoin advocacy in the new frontier of Digital Capital and Digital Credit.
As part of the acquisition, Strive has appointed True North founder Jeff Walton as Chief Executive Officer of True North and Chief Risk Officer of Strive. True North member Ben Werkman will continue to serve on Strive’s board of directors.
This transaction also marks a new expansionary era for the True North media platform, including its Investment Grade Bitcoin podcast and Bitcoin treasury thought leaders,...
Mirasol Advances Large Untested Target Towards Drilling at the Flagship Sobek Copper-Gold Project in the Vicuña District, Chile
Written by Customer Service on . Posted in Public Companies.
Geochemical soil survey defined a large (~1.0 × 0.7 km), prominent and coherent copper-gold-moly anomaly where structurally controlled hydrothermal and tourmaline breccias breach the surface
The 46 South target lies on the southern margin of a district scale (~6 x 6 km) circular magnetic high
Ground-based IP responses and coincident cylindrical shaped magnetic susceptibility and MT anomalies directly underlie the soil anomaly and breccias on surface
Ahead of the drill program we anticipate launching in early November, a Deep Vector IP and MT survey will be deployed to refine geometry and enhance vectoring of the targets
The 46 South target is located just 7 km west of Filo del Sol at the southern end of a parallel 3 km corridor of mineralization
Webcast video presentation highlighting the potential of the 46 South target is available...
Novo Nordisk presents phase 3 data for next-generation amylin cagrilintide, leading to advancement into dedicated clinical programme
Written by Customer Service on . Posted in Public Companies.
Positive results show that the average weight loss was 12.5 kg (11.8% body weight reduction) with cagrilintide compared to 2.5 kg (2.3%) with placebo, after 68 weeks*1,2
Cagrilintide was well-tolerated, with the most common side effects being gastrointestinal; these were mainly transient and mild to moderate in severity1
Based on these results, Novo Nordisk will advance cagrilintide into the dedicated RENEW phase 3 clinical programme later this yearBagsværd, Denmark, 16 September 2025 – Novo Nordisk today presented data from a sub-analysis of the phase 3 REDEFINE 1 trial at the European Association for the Study of Diabetes (EASD) congress 2025 from 15–19 September in Vienna, Austria. This sub-analysis evaluated the efficacy and safety of once-weekly cagrilintide 2.4 mg monotherapy, plus lifestyle intervention, for adults with obesity...
Enerflex Ltd. Announces the Appointment of Paul Mahoney as President, CEO and Director
Written by Customer Service on . Posted in Public Companies.
CALGARY, Alberta, Sept. 16, 2025 (GLOBE NEWSWIRE) — Enerflex Ltd. (TSX: EFX) (NYSE: EFXT) (“Enerflex” or the “Company”) today announced the appointment Paul E. Mahoney as the Company’s President and Chief Executive Officer, effective September 29, 2025. Mr. Mahoney will also join Enerflex’s Board of Directors at the same time. The appointment follows an extensive global search process, which included the evaluation of highly qualified internal and external candidates, and was aided with the support of a global executive search firm.
Kevin Reinhart, Chair of the Board, stated, “We are pleased to welcome Paul as Enerflex’s new President and CEO. With over 30 years of experience across the industrial and energy sectors, Paul is a highly accomplished and seasoned executive. His broad industry experience, proven track record of...
Verona Pharma to Present Additional Analyses of the Phase 3 ENHANCE Studies in COPD at ERS International Congress 2025
Written by Customer Service on . Posted in Public Companies.
Posters support Ohtuvayre® (ensifentrine) as a first-in-class selective dual inhibitor of PDE3 and PDE4 for a broad COPD population
LONDON and RALEIGH, N.C., Sept. 16, 2025 (GLOBE NEWSWIRE) — Verona Pharma plc (Nasdaq: VRNA) (“Verona” or the “Company”), a biopharmaceutical company focused on respiratory diseases, announces two posters on additional analyses from its Phase 3 ENHANCE studies with Ohtuvayre (ensifentrine) for the treatment of chronic obstructive pulmonary disease (“COPD”), will be presented at the European Respiratory Society (“ERS”) International Congress 2025. The abstracts are available to conference participants on the ERS website and will be published in an upcoming issue of the peer reviewed publication, European Respiratory Journal.
Ohtuvayre (ensifentrine) is a first-in-class selective dual inhibitor of the...
Volatus Aerospace Secures Major Multi-Year Agreement with a Leading North American Power Utility to Provide Drone-Based Services
Written by Customer Service on . Posted in Public Companies.
Volatus to provide remotely piloted aircraft system (“RPAS”) inspection, mapping, and data services across 100,000 miles of transmission and distribution lines
TORONTO, Sept. 16, 2025 (GLOBE NEWSWIRE) — Volatus Aerospace Inc. (TSXV: FLT) (OTCQB: TAKOF) (FSE: ABB.F) (“Volatus” or the “Company”), is pleased to announce that it has entered into a multi-year agreement with one of North America’s largest electricity transmission and distribution utilities. Under the agreement, Volatus has been selected to provide remotely piloted aircraft system (“RPAS”) inspection, mapping, and data services across an extensive network of approx. 100,000 miles of transmission and distribution lines. The agreement is set through August 2028, with an option for a two-year extension. Under its terms, Volatus will provide line inspections, vegetation management,...
Small Businesses Face Pressure as Delinquencies Remain Elevated and Uncertainty Continues in Trade Relations
Written by Customer Service on . Posted in Public Companies.
– Credit stress rising in consumer-sensitive sectors and across key provinces –
Equifax Canada Market Pulse — Q2 2025 Quarterly Business Credit Trends Report
TORONTO, Sept. 16, 2025 (GLOBE NEWSWIRE) — Canadian small businesses faced continued financial pressures in the second quarter of 2025, driven by a complex mix of macroeconomic factors and uncertain trade relations, as well as shifts in consumer and household spending, according to the latest Equifax Canada Market Pulse – Quarterly Business Credit Trends Report. Real GDP fell by 0.4 per cent, impacting the overall business outlook.
The Canadian Small Business Health Index has declinedThe Canadian Small Business Health Index — a joint initiative between Equifax Canada and Business Development Bank of Canada that provides a quarterly snapshot of the health of Canadian...
Brunswick Corporation Makes Further Significant Gains at Cannes Boat Show
Written by Customer Service on . Posted in Public Companies.
CANNES, France, Sept. 16, 2025 (GLOBE NEWSWIRE) — Brunswick Corporation (NYSE: BC), the world’s leading marine technology company, delivered an award-winning performance at the 2025 Cannes Boat Show, with increased year-over-year boat sales and outboard market share, and several notable industry awards. Brunswick’s performance at Cannes is an encouraging sign for the upcoming Genoa and Southampton boat shows this week.
Brunswick reported nearly double the total number of boats sold vs. the 2024 Show for its premium brands at the Show: Navan; Boston Whaler; and Sea Ray, suggesting continued strong consumer demand in the luxury and performance segments.
Mercury Marine delivered another strong performance at Cannes, increasing its overall share of outboards boats on display year-over-year by five points to 66%. Growth was fueled by...
